Sign InSummary
On August 3, 2023, T2 Biosystems, Inc. (TTOO) experienced a substantial 44.03% increase in its stock price, driven by news of an extension granted for NASDAQ compliance, however, with negative fundamentals and an overbought RSI, a potential price correction is expected in the short term.
Fundamental Analysis
T2 Biosystems, Inc. (TTOO) is a NASDAQ-listed diagnostic testing company with a current market capitalization of $8.71 million. The company's stock closed at $0.35 on August 3, 2023, a substantial increase of 44.03% from the previous trading day. Despite the recent surge in price, TTOO has an unfavorable PE ratio of -0.04 and a highly negative EPS of -8.18, indicating that the company is currently not profitable. There are 24.89 million shares currently outstanding.
The company is currently under NASDAQ compliance review, and it recently received an extension to regain compliance. Two of the exchange's requirement were that the company must increase its share price above $1 and expand its market capitalization to at least $35 million for 10 consecutive trading days. This news has been a major driving force behind the recent rally in TTOO's stock price.
Technical Analysis
The company's recent stock price surge places its RSI14 at an overbought level of 90, which may indicate a potential price correction in the short term. The stock price is well above the 50-day moving average of $0.10 and much below the 200-day moving average of $0.87. These numbers suggest that the stock has been volatile and subject to short-term rallies over the past year.
The MACD over a three-month period is 0.014436, which is a bullish sign. However, this signal must be corroborated with other indicators due to the high volatility of TTOO’s stock.
The significant trading volume of 474.22 million, compared to the average volume of 63.76 million, further supports the notion that the momentum in the stock's price increase is strong.
Stock Prediction
Given the stock's current momentum and considering the latest news about extensions for NASDAQ compliance, we anticipate that the stock price could continue to climb in the short term. However, the extremely high RSI and the current price being far higher than the 50-day moving average indicate that the stock may be overbought, suggesting a potential price correction.
For the next trading day, August 4, 2023, we expect that the stock price could experience a slight pullback due to a potential price correction. For the upcoming week, the price could stabilize around the level it reaches after the correction, driven by further news around the company's compliance status.
Evaluation
Given the volatility and recent surge in TTOO's stock price, coupled with the poor fundamentals of the company, the stock is categorized as a "Hold." The stock is showing bullish technical signs due to the extension granted from NASDAQ, but the negative EPS, and the highly negative PE ratio are concerning.
The company is largely risky and speculative, clearly reflected in its current volatility. Investors should pay close attention to the ongoing NASDAQ compliance review and should be aware that the price could drop significantly should the company fail to meet the compliance requirements.
Please note that this evaluation is based on the provided data and does not take into account other potential factors that could impact TTOO's stock performance.
